Kidney360Finerenone Added to Renin-Angiotensin System- and Sodium-Glucose Cotransporter 2 Inhibition in Patients with Alport Syndrome: A Two-Center Case SeriesBy Jan Boeckhaus, Fang Wang, Jie Ding, +2Show 2 more authors, Oliver GrossStudy in peopleInterventionsPaperThe paperJan Boeckhaus, Fang Wang, Jie Ding, +2Show 2 more authors, Sima Jami, Yanqin Zhang, Oliver GrossUniversitätsmedizin GöttingenKidney360, 2 Sep 2026doi.org/10.34067/kid.0000001342PubMed 42684838
Diabetes, Obesity & Metabolism·4 Oct 2026GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk